Both in Pharmaceuticals
Nomad Power Solutions vs RenovoRx
Over the past year NMAD returned +1.7% and RNXT returned −25.6%; their daily moves had a correlation of 0.08.
NMAD +1.7% RNXT −25.6%Growth of $1, one year, split-adjusted
| Metric | NMAD | RNXT |
|---|---|---|
| Price | $3.60 | $1.31 |
| Market cap | $58.0M | $59.1M |
| Today | +2.27% | +1.55% |
| 1 month | −17.1% | −5.8% |
| 6 months | — | +47.2% |
| Year to date | — | +55.9% |
| 1 year | — | +20.2% |
| Revenue growth (YoY) | — | +115.4% |
| Gross margin | — | 84.3% |
| Net margin | — | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 29.9× |
| Net cash | — | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 108.4% |
| Short % of float | 11.0% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).